Zydus drug Desidustat for renal anaemia gets regulatory nod in China(Soban News)

CMS International Development and Management Ltd, a wholly-owned subsidiary of CMS, had obtained an exclusive license for the drug from Zydus in 2020

​CMS International Development and Management Ltd, a wholly-owned subsidiary of CMS, had obtained an exclusive license for the drug from Zydus in 2020 by Soban News (international And National News)